[Inflammatory myopathies].
D003131:Combined Modality Therapy; D003882:Dermatomyositis / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009220:Myositis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy
D007166:Immunosuppressive Agents; D008727:Methotrexate